Adagene Inc. (FRA:978)
Germany · Delayed Price · Currency is EUR 3.260
0.00 (0.00%)
At close: Apr 24, 2026
Adagene Market Cap
Adagene has a market cap or net worth of €210.96 million as of April 24, 2026. Its market cap has increased by 236.93% in one year.
Market Cap
210.96M
Enterprise Value
165.69M
Revenue
6.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.26
Market Cap Chart
Since February 9, 2021, Adagene's market cap has decreased from 1.05B to 210.96M, a decrease of -79.83%. That is a compound annual growth rate of -26.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 210.96M | 178.06% |
| Dec 31, 2025 | 75.87M | -10.84% |
| Dec 31, 2024 | 85.09M | 11.10% |
| Dec 29, 2023 | 76.59M | 42.27% |
| Dec 30, 2022 | 53.84M | -82.59% |
| Dec 31, 2021 | 309.16M | -70.44% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.45B |
| Darwin AG | 92.40M |
| 2invest AG | 49.52M |
| Biomark Diagnostics | 35.52M |
| Paion AG | 545.73K |
| co.don AG | 374.13K |
| bioXXmed AG | 244.68K |
| MagForce AG | 122.29K |